ghk-cu hair growth clinical trial human randomized peptide evidence GHK-Cu Copper Peptide Regeneration Review (2018) — Research Summary GHK-Cu Peptide Injection Before and
Description
Week 912: 68 mg once weekly

Evening dosing encounters circadian suppression of autophagy (driven by PER2 gene expression), lower p53 protein levels due to peak MDM2 ubiquitin ligase activity, and potential interference from postprandial insulin signaling if dosed within 4 hours of eating

10.1097/BRS.0b013e3181a55705

European research institutions frequently prefer larger vial formats to support reproducibility requirements in peer-reviewed and grant-funded scientific work
